News
The Food and Drug Administration is considering pulling its authorization of Pfizer’s COVID-19 vaccine for healthy children ...
Activist Starboard Value, one of the first investors to publicly push Salesforce to make changes three years ago, increased ...
Hedge fund Starboard in Q2 took a new position in TripAdvisor (NASDAQ:TRIP) and iShares Russell 2000 ETF (IWM), boosted its ...
The U.S. Food and Drug Administration may not renew its authorization for Pfizer's COVID-19 vaccine approved for children ...
CDC wastewater also shows the XFG variant — nicknamed stratus — is most common in the U.S. Stratus can cause a “razor blade” ...
7h
TipRanks on MSNPfizer’s Latest Clinical Study on Abrocitinib for Pediatric Eczema: Key Insights for Investors
Pfizer Inc ((PFE)) announced an update on their ongoing clinical study.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, ...
Can Boston stay on top in biotech? Find out on Sept 17, 6-9 p.m. EDT to explore talent shifts, funding, and Boston’s future.
The expedited approval of mpox vaccines is critical to addressing this public health emergency. Building on the practice in approving COVID-19 vaccines, this analysis investigates the regulatory ...
Dividend stocks are a time-tested way to retire or protect your portfolio if you are already retired. Their yield can give ...
With federal public health agencies under the helm of Robert F. Kennedy Jr., a longtime vaccine critic, the usual schedule ...
The move would add another barrier for parents who want to vaccinate healthy children ahead of the respiratory virus season.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results